A novel splice site mutation of the LDL receptor gene in a Tunisian hypercholesterolemic family
- 30 June 2008
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 392 (1-2) , 25-29
- https://doi.org/10.1016/j.cca.2008.02.019
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Genetic heterogeneity of autosomal dominant hypercholesterolemiaClinical Genetics, 2007
- Mutation scanning by meltMADGE: Validations usingBRCA1andLDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general populationGenome Research, 2005
- The molecular basis of familial hypercholesterolaemia in Turkish patientsAtherosclerosis, 2005
- No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYP7A1 genes in the Familial Hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genesAtherosclerosis, 2004
- LDL-receptor mutations in EuropeHuman Mutation, 2004
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- Intronic mutations outside of Alu -repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemiaHuman Genetics, 2002
- Familial hypercholesterolemia. Acceptor splice site (G→C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-RHonduras-1 [LDL-R1061(−1) G→C]Atherosclerosis, 1999
- Phenotypic expression of familial hypercholesterolaemia in Central and Southern TunisiaAtherosclerosis, 1993
- An acceptor splice site mutation in intron 16 of the low density lipoprotein receptor gene leads to an elongated, internalization defective receptorAtherosclerosis, 1993